Furthermore, systemic lupus patients overexpress ACE2 as a result of hypomethylation, and their vascular complications respond very well to hydroxychloroquine treatment, being circumstantial evidence of a speculative link between ACE2 and vascular complications in COVID‐19 [109]. This evidence concerns the gene ACE2 and COVID-19.